Gaplinc regulates myeloid metabolic pathways in trans in endotoxic shock

The long noncoding RNA (lncRNA) Gaplinc is a known regulator of the innate immune response; however, the systemic mechanisms governing its influence on survival during endotoxic shock remain incompletely understood. Here, we establish Gaplinc as a dosage-dependent immune and metabolic rheostat. While Gaplinc knockout (KO) mice exhibit elevated baseline immune response genes (IRGs) and resistance to lipopolysaccharide (LPS)-induced shock, we demonstrate that transgenic Gaplinc overexpression produces the opposite phenotype: suppressed baseline IRGs, diminished nuclear p65, and hypersensitivity to endotoxemia. Analysis of heterozygous and rescue models reveals that Gaplinc functions in trans and is haploinsufficient, requiring strict transcript dosage to maintain wild-type immune homeostasis. To uncover the mechanistic basis of this survival advantage, we performed RNA Antisense Purification (RAP-MS) and identified the mitochondrial enzyme MCCC1 as a primary Gaplinc binding partner. Loss of Gaplinc drives systemic metabolic reprogramming, characterized by reduced mitochondrial reactive oxygen species and a protective lipidome featuring elevated lysophosphatidylcholines and diminished free fatty acids. Finally, while myeloid-specific conditional KOs confer partial protection against LPS-induced hypothermia, tissue-wide expression mapping and sex-dimorphic clinical chemistries suggest a broader, multisystemic role for the lncRNA. Collectively, these data demonstrate that Gaplinc bridges transcriptomic immune regulation with systemic lipid and metabolic output, dictating survival outcomes in systemic inflammation.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-16
DOI
https://doi.org/10.1073/pnas.2616060123
Primary Topic
Immune Response and Inflammation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Gaplinc regulates myeloid metabolic pathways in trans in endotoxic shock

Martin Hrabě de Angelis, Helmut Fuchs, Eric Malekos, Birgit Rathkolb et al.
2 links
Proceedings of the National Academy of Sciences
Immune Response and Inflammation
article

Gaplinc regulates myeloid metabolic pathways in trans in endotoxic shock

Martin Hrabě de Angelis, Helmut Fuchs, Eric Malekos, Birgit Rathkolb, Susan B Carpenter, Juan Antonio Aguilar‐Pimentel, E. Camilla Forsberg, Apple Cortez Vollmers, David F. Boyd, Sol J. Katzman, Valérie Gailus‐Durner, Judith Hellman, Valeriya Smaliy, Alexa Mozqueda, Lisa Sudek, Diana Escalona, Steven Liang, Stephanie Smith-Berdan
article en

Abstract

The long noncoding RNA (lncRNA) Gaplinc is a known regulator of the innate immune response; however, the systemic mechanisms governing its influence on survival during endotoxic shock remain incompletely understood. Here, we establish Gaplinc as a dosage-dependent immune and metabolic rheostat. While Gaplinc knockout (KO) mice exhibit elevated baseline immune response genes (IRGs) and resistance to lipopolysaccharide (LPS)-induced shock, we demonstrate that transgenic Gaplinc overexpression produces the opposite phenotype: suppressed baseline IRGs, diminished nuclear p65, and hypersensitivity to endotoxemia. Analysis of heterozygous and rescue models reveals that Gaplinc functions in trans and is haploinsufficient, requiring strict transcript dosage to maintain wild-type immune homeostasis. To uncover the mechanistic basis of this survival advantage, we performed RNA Antisense Purification (RAP-MS) and identified the mitochondrial enzyme MCCC1 as a primary Gaplinc binding partner. Loss of Gaplinc drives systemic metabolic reprogramming, characterized by reduced mitochondrial reactive oxygen species and a protective lipidome featuring elevated lysophosphatidylcholines and diminished free fatty acids. Finally, while myeloid-specific conditional KOs confer partial protection against LPS-induced hypothermia, tissue-wide expression mapping and sex-dimorphic clinical chemistries suggest a broader, multisystemic role for the lncRNA. Collectively, these data demonstrate that Gaplinc bridges transcriptomic immune regulation with systemic lipid and metabolic output, dictating survival outcomes in systemic inflammation.

Proceedings of the National Academy of SciencesVol. 123(47)
University of California, San Francisco (US), University of California, Santa Cruz (US), Helmholtz Zentrum München (DE), German Center for Diabetes Research (DE), Technical University of Munich (DE), Ludwig-Maximilians-Universität München (DE)
National Institute of Allergy and Infectious Diseases
Good health and well-being
Immune Response and Inflammation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon